Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation.
作者信息
Angiolillo Dominick J, Cao Davide, Baber Usman, Mehran Roxana
出版信息
JACC Cardiovasc Interv. 2024 Feb 12;17(3):452-453. doi: 10.1016/j.jcin.2023.12.035.
PMID:38355276
Abstract
摘要
相似文献
1
Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation.回复：解读替格瑞洛引起的呼吸困难：在停药前进行中枢性呼吸暂停筛查。
JACC Cardiovasc Interv. 2024 Feb 12;17(3):452-453. doi: 10.1016/j.jcin.2023.12.035.
2
Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation.解读替格瑞洛所致呼吸困难：在停药前进行中枢性呼吸暂停筛查
JACC Cardiovasc Interv. 2024 Feb 12;17(3):450-451. doi: 10.1016/j.jcin.2023.12.019.
3
Ticagrelor-Induced Dyspnea: A Controllable Side Effect.替格瑞洛所致呼吸困难：一种可控的副作用。
JACC Cardiovasc Interv. 2023 Oct 23;16(20):2525-2527. doi: 10.1016/j.jcin.2023.09.009.
4
Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.有和没有替格瑞洛相关呼吸困难的患者的腺苷和替格瑞洛血浆水平
Circulation. 2018 Aug 7;138(6):646-648. doi: 10.1161/CIRCULATIONAHA.118.034489.
5
Ticagrelor and Central Sleep Apnea.替格瑞洛与中枢性睡眠呼吸暂停
J Am Coll Cardiol. 2018 May 22;71(20):2378-2379. doi: 10.1016/j.jacc.2018.03.447.
6
Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.替格瑞洛与中枢性睡眠呼吸暂停：撤药及重新用药的影响
Br J Clin Pharmacol. 2019 Aug;85(8):1855-1858. doi: 10.1111/bcp.13967. Epub 2019 Jun 17.
7
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.在常规临床实践中接受冠状动脉血运重建的患者中过早停用替格瑞洛的频率、原因和影响：来自伯尔尼经皮冠状动脉介入治疗注册研究的结果。
Circ Cardiovasc Interv. 2018 May;11(5):e006132. doi: 10.1161/CIRCINTERVENTIONS.117.006132.
8
Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.在需要质子泵抑制剂和延长抗血小板治疗的患者中，冠状动脉支架置入术后替格瑞洛单药治疗。
Catheter Cardiovasc Interv. 2022 Jul;100(1):83-84. doi: 10.1002/ccd.30315.
9
Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel.替格瑞洛或氯吡格雷治疗的急性心肌梗死患者发生感染事件的风险。
Eur J Intern Med. 2021 Mar;85:121-123. doi: 10.1016/j.ejim.2020.10.016. Epub 2020 Nov 14.
10
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.替格瑞洛与氯吡格雷用于择期冠状动脉支架置入术的比较：一项双盲随机临床试验。
J Interv Cardiol. 2023 Dec 26;2023:5544440. doi: 10.1155/2023/5544440. eCollection 2023.
引用本文的文献
1
Medication-induced central sleep apnea: beyond the unification of concepts, seizing the opportunity to precision medicine.药物性中枢性睡眠呼吸暂停：超越概念统一，抓住精准医学机遇。
Sleep. 2024 Aug 14;47(8). doi: 10.1093/sleep/zsae119.
Zotero 插件